BioSpace News Archive

Pharmagreen Biotech, Inc. (f/k/a Air Transport Group Holdings, Inc.), (OTC PINKS: AITGD), a cannabis biotech company focused on producing cannabis starter plantlets through its proprietary tissue culture process is pleased to announce that its wholly owned Canadian subsidiary, WFS Pharmagreen Inc., is currently completing its pre-construction phase of its 62,000 square foot cannabis biotech complex.

Crown Bioscience extends its existing portfolio of humanized drug target models (HuGEMM™) to its San Diego facility.

Sedor Pharmaceuticals, LLC (Sedor) announced that the US FDA accepted its 505(b)2 NDA (210864) for Sedor’s lead program, IM/IV Captisol-Enabled™ (CE) Fosphenytoin,(fosphenytoin sodium and sulfobutylether beta-cyclodextrin sodium for injection) with a PDUFA date of March 22, 2019.

CloudMedx announced a research collaboration with the UCSF Department of Orthopaedic Surgery to study how patient-generated health care data collected from consumer-grade wearable sensors may predict clinical outcomes following hip and knee replacement surgery.

United Rotorcraft has received a European Aviation Safety Agency (EASA) Supplemental Type Certificate (STC) for its modular emergency medical services (EMS) interiors for both the AW169 and AW139 helicopters.

B Sciences, Inc has contracted Adherence Compliance for its Chief Compliance Officer Program and Adherence SCORE App

Ongoing Phase 1 basket study of PV-10 for cancers of the liver expanded to include single-center cohort of metastatic uveal melanoma patients

Integer Holdings Corporation announced that it has received FDA and CE Mark approval for their new radial access introducer, RadialSeal™.

Axsome to host conference call and webcast on Wednesday, August 8, 2018 at 8:00 AM Eastern Time

Myriad Genetics, Inc. announced that it will hold its fiscal fourth-quarter 2018 sales and earnings conference call with investors and analysts at 4:30 p.m. EDT on Tuesday, August 14, 2018.